NEW YORK (AP) — Teva Pharmaceutical is buying Auspex Pharmaceuticals for about $3.2 billion in a move to strengthen its position on central nervous system condition treatments.
Search Results - stltoday.com, St. Louis Post-Dispatch: Business
Mon, 03/30/2015 - 4:31am
NEW YORK (AP) — Teva Pharmaceutical is buying Auspex Pharmaceuticals for about $3.2 billion in a move to strengthen its position on central nervous system condition treatments.